Trends in vaccination coverage among children aged 12-23 and 24-35 months in Mexico. Ensanut 2012 and Ensanut 100k

Objective. To evaluate and compare vaccination coverage among children aged 12-23 and 24-35 months living in localities with less than 100 000 inhabitants in Encuesta Nacional de Salud y Nutrición (Ensanut) 2012 and Ensanut 100k (2018). Materials and methods. Estimate of coverage with both surveys....

Full description

Saved in:
Bibliographic Details
Published in:Salud pública de México 2019-12, Vol.61 (6, nov-dic), p.809-820
Main Authors: Norma Mongua-Rodríguez, Celia Hubert, Elizabeth Ferreira-Guerrero, Filipa de Castro, Leticia Ferreyra-Reyes, Aremis Villalobos-Hernández, Pablo Cruz-Hervert, Guadalupe Delgado-Sánchez, José Luis Díaz-Ortega, Martín Romero-Martínez, Lourdes García-García
Format: Article
Language:English
Subjects:
cobertura de vacunación
infantes
méxico
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To evaluate and compare vaccination coverage among children aged 12-23 and 24-35 months living in localities with less than 100 000 inhabitants in Encuesta Nacional de Salud y Nutrición (Ensanut) 2012 and Ensanut 100k (2018). Materials and methods. Estimate of coverage with both surveys. Results. Between 2012 and 2018, according to proof and self-report, the coverage of the basic scheme was maintained in children aged 12-23 (51.6 vs. 60.2%) and 24-35 months (51.4 vs. 50.0%). Similarly, only with proof (53.9 vs. 51.3% and 52.8 vs. 44.2%). In children aged 24-35 months, the coverage of the reinforced basic scheme reinforcements with probative document and self-report (30.9 vs. 34.0%) and only with reinforcements (30.2 vs. 27.8%) was maintained. Coverage with second and third doses of hepatitis B in both age groups decreased; additionally, first dose of measlesmumps-rubella vaccine (SRP, in Spanish) and third dose of Pentavalent in children aged 24-35 months. Conclusions. Coverages were maintained by schemes, despite reductions in hepatitis B, pentavalent and SRP.
ISSN:0036-3634
DOI:10.21149/10559